Eugene T. Grygielko

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur et al. · Molecular Pharmacology · 2002 · 647 citations

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

Maj Petersen, Midory Thorikay, Martijn Deckers et al. · Kidney International · 2007 · 213 citations · Full text

Inflammation, Fibrosis, Urology +11

Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

Eugene T. Grygielko, W. Martin, Christopher Tweed et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 186 citations

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype

Christine Y. Ivashchenko, G. C. Teg Pipes, Irina M. Lozinskaya et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 150 citations

Cardiac Muscle, Cardiac Progenitor Cells, Cardiovascular Function +21